Catalyst
Slingshot members are tracking this event:
Heron Therapeutics Announces U.S. FDA Approval of SUSTOL (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| HRTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 10, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Granisetron, Chemotherapy-induced Nausea And Vomiting, Sustol, 5-ht3, Serotonin-3 Receptor Antagonist, Anthracycline, Cyclophosphamide, Emetogenic Chemotherapy
